Entity

Vertex Pharmaceuticals

American pharmaceutical company

Express your sentiment! Sign in!
Entity sentiment
1
Business
Vertex Pharmaceuticals Will Report Q3 Earnings Today Amid Mixed Predictions
Jim Cramer Vertex Pharmaceuticals
Business
The company tops Q1 profit estimates on robust demand for cystic fibrosis treatments
Vertex Pharmaceuticals
Business
Alpine Immune Sciences is going to be bought by Vertex Pharmaceuticals for $4.9 billion
Alpine Immune Sciences (United States) Vertex Pharmaceuticals
You've reached the end